Clinical trial
Mesenchymal Stromal Cells (MSC) for the Treatment of Severe (Grade II-IV) Steroid-resistant Graft Versus Host Disease (GVHD): a Phase I Trial
NCT01764100 is registered in ClinicalTrials.gov with Ettore Biagi, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mesenchymal Stromal Cells (MSC) for the Treatment of Severe (Grade II-IV) Steroid-resistant Graft Versus Host Disease (GVHD): a Phase I Trial
- Lead sponsor
- Ettore Biagi, MD
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- September 30, 2009
- Completion date
- September 30, 2013
- Enrollment
- 10 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.